2025-10-30 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc. (HIMS) based on the provided data, formatted for a clear English report with simple numbers and concise analysis.

**Hims & Hers Health Inc. (HIMS) Analysis**

**Company Overview:** Hims & Hers Health Inc. is a telehealth company offering personalized health and wellness solutions.

**1. Performance Relative to S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 215.62%
*   **VOO Cumulative Return:** 78.00%
*   **Spread (HIMS - VOO):** 150.6
*   **Relative Spread Percentile:** 58.1

**Analysis:** HIMS has significantly outperformed the S&P 500. The relative spread percentile of 58.1 indicates that the current outperformance is above the historical median.

**Alpha/Beta Analysis (Selected Years):**

| Year Range | CAGR     | MDD    | Alpha   | Beta  | Cap (B) |
| :---------- | :------- | :----- | :------ | :---- | :------ |
| 2019-2021   | -42.0%   | 74.4%  | -81.0%  | 0.0   | 1.5     |
| 2020-2022   | -19.0%   | 78.6%  | -18.0%  | -0.0  | 1.4     |
| 2021-2023   | -65.0%   | 78.6%  | -67.0%  | -0.1  | 2.0     |
| 2022-2024   | 119.0%   | 79.4%  | 98.0%   | -0.0  | 5.5     |
| 2023-2025   | 220.0%   | 80.8%  | 152.0%  | 0.1   | 10.9    |

**Analysis:**
*The CAGR shows a strong recovery and growth in recent periods (2022-2025).
*The MDD (Maximum Drawdown) remained high, indicating significant volatility.
*Alpha is positive in the most recent period, suggesting HIMS is generating excess returns relative to its risk.
*Beta is around 0, indicating that HIMS' price movements are not highly correlated with the overall market.
*Market capitalization has significantly increased, reflecting company growth.

**2. Recent Price Action**

*   **Current Price:** 48.13
*   **Last Market Data:** Price: 48.12, Previous Close: 47.12, Change: 2.13
*   **5-day Moving Average:** 48.22
*   **20-day Moving Average:** 53.45
*   **60-day Moving Average:** 50.93

**Analysis:** The current price is below the 20-day and 60-day moving averages, suggesting a recent downtrend. The price increase relative to the previous close shows a little rebound.

**3. Technical Indicators & Outlook**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 35.61
*   **PPO:** -1.91
*   **Hybrid Signal:** cash_0%_Buy 100% of cash
*   **Recent Relative Divergence Change (20-day):** -8.1 (Negative - Short-term Decline)
*   **Expected Return:** 4.8% (vs. S&P 500, long-term)

**Analysis:**
*   The MRI suggests the market views HIMS as a relatively safe investment.
*   The RSI indicates the stock is nearing oversold conditions.
*   The negative PPO suggests a bearish trend.
*   The recent negative divergence change indicates weakening momentum.
*   A long-term investment horizon projects outperformance of the S&P 500.

**4. Recent News & Events**

*   Several articles focus on analyst estimates, comparing HIMS to competitors, and discussing upcoming earnings.
*   One article identifies HIMS as a potentially profitable stock.
*   Another one focuses on upcoming Earnings expected to grow.

**Analysis:** The news is a mix of positive and cautious sentiment. Analyst opinions and upcoming earnings reports appear to be key drivers of recent attention.

**4-2. Analyst Opinions**

*   **Consensus:** Hold (2.93)
*   **Target Price:** 47.77 (Average)
*   **Recent Rating Changes:** No specific changes provided.

**Analysis:** Analyst consensus is neutral ("Hold"). The average target price is slightly below the current price, suggesting limited upside potential according to analysts.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
| :---------- | :--- | :------------- |
| 2025-08-04 | 0.19 | 0.54 B$ |
| 2025-05-05 | 0.22 | 0.59 B$ |
| 2024-11-04 | 0.35 | 0.40 B$ |
| 2024-08-05 | 0.06 | 0.32 B$ |
| 2025-08-04 | 0.06 | 0.32 B$ |

**Analysis:** EPS and Revenue show fluctuating earnings with an increasing trend in revenue.

**6. Financial Information**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :-------------- |
| 2025-06-30 | \$0.54B   | 76.39%          |
| 2025-03-31 | \$0.59B   | 73.50%          |
| 2024-12-31 | \$0.48B   | 76.81%          |
| 2024-09-30 | \$0.40B   | 79.16%          |
| 2024-06-30 | \$0.32B   | 81.30%          |

| Quarter    | Equity    | ROE     |
| :--------- | :-------- | :------ |
| 2025-06-30 | \$0.56B   | 7.55%   |
| 2025-03-31 | \$0.55B   | 9.01%   |
| 2024-12-31 | \$0.48B   | 5.46%   |
| 2024-09-30 | \$0.44B   | 17.18%  |
| 2024-06-30 | \$0.36B   | 3.67%   |

**Analysis:** Revenue shows a positive trend. Profit margins are high and relatively stable. Equity is increasing, and ROE fluctuates.

**7. Overall Summary**

HIMS has shown strong outperformance relative to the S&P 500, driven by significant revenue growth. Recent price action indicates a short-term downtrend, and the RSI is nearing oversold conditions. Analyst opinions are neutral. The MRI suggests the market views HIMS as having investment potential. Long-term, the stock is expected to outperform the S&P 500.
